Syndicate This week's upcoming IPO's and secondary offerings

Week of July 20 to July 24, 2024

This Week's Deals to be Priced

07/21 - Tuesday

Symbol

Issuer

Type

Price

Managers

QIWI

Qiwi
Qiwi
Secondary
Canceled $19.19
6.8M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, UBS & VITB

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

07/21 - Tuesday

Symbol

Issuer

Type

Price

Managers

JAMF

Jamf Holding
Jamf Holding
IPO
Priced: $26.00
18M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, JPMorgan, BofA & Barclays, RBC Capital, MIZU, HSBC, Canaccord, JMP Securities, Piper Sandler, William Blair, Loop Capital, CastleOak

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PSTH

Pershing Square Tontine Holdings
Pershing Square Tontine Holdings
IPO
Priced: $20.00
200M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Jefferies & UBS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CTSO

CytoSorbents
CytoSorbents
Secondary
Priced: $9.50
5.263M
TD Cowen & Leerink

Pricing after close
Deal analysis and details

Managers: TD Cowen & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KNSA

Kiniksa
Kiniksa
Secondary
Priced: $21.00
5.953M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, BofA & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OPCH

Option Care Health
Option Care Health
Secondary
Priced: $12.50
18M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Barclays, Deutsche Bank, Goldman Sachs, JPMorgan, Morgan Stanley, Truist, William Blair & Lake Street

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VERB

VERB Technology
VERB Technology
Secondary
Priced: $1.10
10.909M
Ladenburg

Pricing after close

Managers: Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CASI

Casi Pharmaceuticals
Casi Pharmaceuticals
Spot Secondary
Priced: $1.90
20M
Oppenheimer,...

Pricing after close

Managers: Oppenheimer, Brookline

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HTLD

Heartland Express
Heartland Express
Spot Secondary
Priced: $20.50
3.261M
Morgan Stanley

Pricing after close

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/22 - Wednesday

Symbol

Issuer

Type

Price

Managers

MEG

Montrose Environmental
Montrose Environmental
IPO
Priced: $15.00
10M
BofA & William Blair,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA & William Blair, BNP Paribas, Capital One, Stifel, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BNTX

BioNTech
BioNTech
Secondary
Priced: $93.00
5.5M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, BofA & Berenberg, UBS, Canaccord, COMZ, Wolfe Research, BRYN

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AUPH

Aurinia Pharmaceuticals
Aurinia Pharmaceuticals
Spot Secondary
Priced: $15.00
13.333M
Jefferies & Leerink

Pricing after close
Deal analysis and details

Managers: Jefferies & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
INUV

Inuvo
Inuvo
Spot Secondary
Priced: $.50
20M
Alliance Global Partners

Pricing after close

Managers: Alliance Global Partners

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/23 - Thursday

Symbol

Issuer

Type

Price

Managers

ANNX

Annexon
Annexon
IPO
Priced: $17.00
14.75M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, BofA & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
INZY

Inozyme
Inozyme
IPO
Priced: $16.00
7M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, TD Cowen & Piper Sandler, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ITOS

iTeos Therapeutics
iTeos Therapeutics
IPO
Priced: $19.00
10.586M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Leerink & Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NRIX

Nurix Therapeutics
Nurix Therapeutics
IPO
Priced: $19.00
11M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Piper Sandler, Stifel & Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MARA

Marathon Patent Group
Marathon Patent Group
Secondary
Priced: $.90
6.667M
H.C. Wainwright

Pricing after close

Managers: H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access